Aggravation of generalized epilepsies

Epilepsia

Volumn 39, Issue SUPPL. 3, 1998, Pages

  Berkovic, Samuel F ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Aggravation; Anticonvulsants; Epilepsy; Proconvulsants; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; SODIUM CHANNEL; VALPROIC ACID; VIGABATRIN;

CALCIUM CURRENT; CONFERENCE PAPER; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; EPILEPSY; FACILITATION; HUMAN; PRIORITY JOURNAL; SPIKE WAVE;

EID: 0031923912     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb05115.x     Document Type: Conference Paper

References (35)

1. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
2. Loiseau P, Duche B, Loiseau J. Classification of epilepsies and epileptic syndromes in two different samples of patients. Epilepsia 1991;32:303-9.
3. Berkovic SF, Andermann F, Andermann E, Gloor P. Concepts of absence epilepsies: discrete syndromes or biological continuum? Neurology 1987;37:993-1000.
4. Reutens DC, Berkovic SF. Idiopathic generalized epilepsy of adolescence: are the syndromes clinically distinct? Neurology 1995; 45:1469-76.
5. Chadwick D. Standard approach to antiepileptic drug treatment in the United Kingdom. Epilepsia 1994;35(suppl 4):s3-10.
6. Pellock JM. Standard approach to antiepileptic drug treatment in the United States. Epilepsia 1994;35(suppl 4):s11-8.
7. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996; 334:168-75.
8. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:1583-90.
9. Ferrendelli JA. Relating pharmacology to clinical practice: the pharmacological basis of rational polytherapy. Neurology 1995;45 (suppl 2):s12-6.
10. Berkovic SF. Adults with epilepsy; is monotherapy the only answer? Epilepsia 1997;38(suppl 2):s9-12.
11. Macdonald RL, Kelly KM. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 1994;35(suppl 4):s41-50.
12. Shields WD, Saslow E, Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983;33:1487-9.
13. Johsen SD, Tarby TJ, Sidell AD. Carbamazepine-induced seizures. Ann Neurol 1984;16:392-3.
14. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986;27:706-10.
15. Snead OC, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916-21.
16. Horn CS, Ater SB, Hurst DL. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 1986;2:340-5.
17. Mutoh K, Okuno T, Mitsuyoshi I, Hayakawa T, Hamada Y, Mikawa H. Induction of tonic spasms by carbamazepine: observations on 2 infants. Jpn J Psychiatry Neurol 1993;47:304-5.
18. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia 1994;35:1026-8.
19. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5 year prospective study. Epilepsia 1994;35:285-96.
20. Levy LL, Fenichel GM. Diphenylhdantoin-activated seizures. Neurology 1965;15:716-22.
21. Osorio I, Peltzer J, Reed R. Phenytoin and carbamazepine exacerbate primary generalized epilepsy. Epilepsia 1996;37(suppl 5): 93.
22. Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ. "Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 1983;2:838-42.
23. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 1985;72:449-59.
24. Steinhoff BJ, Stodieck SR. Temporary abolition of seizure activity by flumazenil in a case of valproate-induced non-convulsive epilepticus. Seizure 1993;2:261-5.
25. Tassinari CA, Dravet C, Roger J, et al. Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia 1972;13:421-35.
26. Bittencourt PRM, Richens A. Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome. Epilepsia 1981;24:281-2.
27. DiMario FJ Jr, Clancy RR. Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. Pediatr Neurol 1988;4:249-51.
28. Roussounis SH, Rudolf N de M. Clonazepam in the treatment of children with intractable seizures. Dev Med Child Neurol 1977;19: 326-34.
29. Gordon N. Treatment of epilepsy with α-ethyl-α-methylsuccinide. Neurology 1961;11:266-8.
30. Todorov AB, Lenn NJ, Gabor AJ. Exacerbation of generalized nonconvulsive seizures with ethosuximide therapy. Arch Neurol 1978;35:389-91.
31. Findeis B. Possibility for provoking grand mal series in ethosuximide therapy: 2 case reports. Psychiatr Neurol Med Psychol 1990; 42:576-7.
32. Lortie A, Chiron C, Mumford J, Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993;43(suppl 5):s24-7.
33. Vossler DG. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin. Neurology 1996;46:852-3.
34. Scheyer RD, Assaf BA, Spencer SS, Mattson RH. Gabapentin related myoclonus. Epilepsia 1996;37(suppl 5):203.
35. Reeves AL, So EL, Sharbrough FW, Krahn LE. Movement disorders associated with the use of gabapentin. Epilepsia 1996;37:988-90.